Biomarkers for severe eosinophilic asthma.

Biomarkers for severe eosinophilic asthma.

The last decade has seen the approval of several new biologics for the treatment of severe asthma-targeting specific endotypes and phenotypes. This review will examine how evidence generated from the mepolizumab clinical development program showed that blood eosinophil counts, rather than sputum or...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Yancey, S, Keene, O, Albers, F, Ortega, H, Bates, S, Bleecker, E, Pavord, I
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	Elsevier 2017

Những quyển sách tương tự

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
Bằng: Yancey, S, et al.
Được phát hành: (2016)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Bằng: Ortega, H, et al.
Được phát hành: (2016)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
Bằng: Gunsoy, N, et al.
Được phát hành: (2017)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
Bằng: Shrimanker, R, et al.
Được phát hành: (2018)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Bằng: Pavord, I, et al.
Được phát hành: (2012)

Mepolizumab treatment in patients with severe eosinophilic asthma.
Bằng: Ortega, H, et al.
Được phát hành: (2014)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Bằng: Bel, E, et al.
Được phát hành: (2014)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
Bằng: Steven W. Yancey, et al.
Được phát hành: (2019-09-01)

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
Bằng: Shrimanker, R, et al.
Được phát hành: (2019)

Glucocorticoids and mepolizumab in eosinophilic asthma.
Bằng: Bel, E, et al.
Được phát hành: (2014)

Mepolizumab, quality of life, and severe eosinophilic asthma.
Bằng: Pavord, I
Được phát hành: (2017)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Bằng: Howell, I, et al.
Được phát hành: (2024)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
Bằng: Prazma CM, et al.
Được phát hành: (2021-06-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
Bằng: Imran Howell, et al.
Được phát hành: (2024-07-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
Bằng: Terufumi Shimoda, et al.
Được phát hành: (2017-07-01)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
Bằng: Charlene M. Prazma, et al.
Được phát hành: (2019-05-01)

Eosinophils in asthma and airway hyperresponsiveness.
Bằng: Brightling, C, et al.
Được phát hành: (2004)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
Bằng: Rastogi, S, et al.
Được phát hành: (2017)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Bằng: Kulkarni, N, et al.
Được phát hành: (2010)

Non-eosinophilic asthma and the innate immune response.
Bằng: Pavord, I
Được phát hành: (2007)

Severe eosinophilic asthma: a roadmap to consensus.
Bằng: Buhl, R, et al.
Được phát hành: (2017)

Mepolizumab in refractory eosinophilic asthma.
Bằng: Pavord, I, et al.
Được phát hành: (2010)

IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma
Bằng: Luo, J, et al.
Được phát hành: (2024)

A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels
Bằng: Haughney, J, et al.
Được phát hành: (2017)

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
Bằng: Mi-Kyeong Kim, et al.
Được phát hành: (2021-03-01)

Eosinophilic bioactivities in severe asthma
Bằng: Tara F. Carr, et al.
Được phát hành: (2016-01-01)

Non-eosinophilic corticosteroid unresponsive asthma.
Bằng: Pavord, I, et al.
Được phát hành: (1999)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Bằng: Shrimanker, R, et al.
Được phát hành: (2017)

Controversies in allergy: should severe asthma with eosinophilic phenotype always be treated with anti-IL-5 therapies
Bằng: Pavord, I, et al.
Được phát hành: (2019)

Eosinophils in asthma and other allergic diseases.
Bằng: Wardlaw, A, et al.
Được phát hành: (2000)

The significance of eosinophilic airway inflammation in asthma
Bằng: Pavord, I, et al.
Được phát hành: (2002)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
Bằng: Brightling, C, et al.
Được phát hành: (2003)

Asthma heterogeneity and severity
Bằng: Tara F. Carr, et al.
Được phát hành: (2016-01-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
Bằng: Pavord, I, et al.
Được phát hành: (2017)

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
Bằng: Frank C. Albers, et al.
Được phát hành: (2019-07-01)

Eosinophils in COPD: just another biomarker?
Bằng: Bafadhel, M, et al.
Được phát hành: (2017)

Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants.
Bằng: Anees, W, et al.
Được phát hành: (2002)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
Bằng: Moran, AM, et al.
Được phát hành: (2020)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
Bằng: Lavoie, G, et al.
Được phát hành: (2024)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Bằng: Shrimanker, R, et al.
Được phát hành: (2017)